Eric Halioua is the founder of PDC*line Pharma. PDC*line Pharma has raised $68M in total funding. Latest round: Series B. Based in Liège, Belgium.
Eric Halioua is the President and CEO of PDC*line Pharma, a clinical-stage biotechnology company developing off-the-shelf therapeutic cancer vaccines based on plasmacytoid dendritic cells. He was appointed President and CEO in December 2016 when the company raised its first €4 million funding round to advance its immuno-oncology platform toward clinical proof of concept. Halioua also serves as a board member of Essenscia (Bio.be), a Belgian science and technology federation.
Full founder directory · Investor directory · Company funding database · Fundraising library